MNPR icon

Monopar Therapeutics
MNPR

Overview Fund Trends Analyst Outlook Journalist POV

4 hedge funds and large institutions have $439K invested in Monopar Therapeutics in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$216K
2
+$177K
3
+$25K
4
UBS Group
UBS Group
Switzerland
+$21K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$216K
2
$177K
3
$25K
4
$21K